Altre lingue BriaCell Therapeutics Corp. Nasdaq

Azioni

BCTX

CA1079301091

Tempo reale stimato Cboe BZX Altri mercati azionari 17:01:07 14/05/2024			Variaz. 5gg	Var. 1 gen.
2,215 ^USD	-0,69%		+2,41%	-61,66%

10/04	Il poster preclinico di BriaCell 2024 AACR conferma la forte attività antitumorale di Bria-OTS+? e Bria-PROS+? Candidati clinici per il cancro al seno e alla prostata	CI
09/04	BriaCell presenterà gli ultimi dati di Bria-IMT in presentazioni poster all'AACR 2024	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting	24/04
BriaCell Announces Oral and Poster Presentations at ASCO 2024	24/04
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer	10/04
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+? and Bria-PROS+? Clinical Candidates for Breast and Prostate Cancer	10/04
BriaCell to Showcase Latest Bria-IMT Data in Poster Presentations at 2024 AACR	09/04
BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR	09/04
BriaCell Therapeutics : NOTICE OF NO AUDITOR REVIEW OF THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K	02/04
BriaCell Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	18/03
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies	07/03
BriaCell to Present Clinical Data in CNS Metastasis and Antibody-Drug Conjugate Resistant Breast Cancer at AACR Conference	06/03
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference	06/03
BriaCell Provides Update on Alleged Illegal Trading of Public Securities	27/02
BriaCell Announces Strong Clinical Data in Breast Cancer Patients	07/02
BriaCell Therapeutics Corp. Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	07/02
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	07/02
Toronto Stocks Rally; Precision Drilling Rises on 4Q Profit Growth	06/02
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing	06/02
Briacell Therapeutics Corp. Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates Gmp Manufacturing	06/02
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting	31/01
BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast Cancer	04/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BriaCell Therapeutics Corp. Nasdaq

Azioni

BCTX

CA1079301091

Altre lingue

Filtri